Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia-Reference-Cited by-同舟云学术

Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia

Published:1997-11-14 Issue:5341 Volume:278 Page:1291-1295
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Wong Joseph K.¹²³,Hezareh Marjan¹²³,Günthard Huldrych F.¹²³,Havlir Diane V.¹²³,Ignacio Caroline C.¹²³,Spina Celsa A.¹²³,Richman Douglas D.¹²³

Affiliation:

1. J. K. Wong, M. Hezareh, H. F. Günthard, C. C. Ignacio, C. A. Spina, Departments of Medicine and Pathology, University of California, San Diego, School of Medicine, 9500 Gilman Drive, La Jolla, CA 92093, USA.

2. D. V. Havlir, Departments of Medicine and Pathology, University of California, San Diego, School of Medicine, 9500 GIlman Drive, La Jolla, CA 92093, USA, and Treatment Center, University of California, San Diego, 2760 Fifth Avenue, Suite 300, San Diego, CA 92103, USA.

3. D. D. Richman, Departments of Medicine and Pathology, University of California, San Diego, School of Medicine, 9500 Gilman Drive, La Jolla, CA 92093, USA, and Veterans Affairs San Diego Healthcare System, San Diego, CA 92063, USA.

Abstract

In evaluating current combination drug regimens for treatment of human immunodeficiency virus (HIV) disease, it is important to determine the existence of viral reservoirs. After depletion of CD8 cells from the peripheral blood mononuclear cells (PBMCs) of both patients and normal donors, activation of patient CD4 lymphocytes with immobilized antibodies to CD3 and CD28 enabled the isolation of virus from PBMCs of six patients despite the suppression of their plasma HIV RNA to fewer than 50 copies per milliliter for up to 2 years. Partial sequencing of HIV pol revealed no new drug resistance mutations or discernible evolution, providing evidence for viral latency rather than drug failure.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference34 articles.

1. Gulick R. M., et al., N. Engl. J. Med. 337, 734 (1997);

2. ; R. M. Gulick et al. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy Toronto Canada 28 September–1 October 1997 (American Society for Microbiology Washington DC 1997) p. 259.

3. Wong J. K., et al., Proc. Natl. Acad. Sci. U.S.A. 94, 12574 (1997).

4. M. Markowitz et al. Fourth Conference on Retroviruses and Opportunistic Infections 22–26 January 1997 (Infectious Diseases Society of America Foundation for Retrovirology and Human Health Alexandria VA 1997) p. 207.

5. Perelson A. S., et al., Nature 387, 188 (1997).

Cited by 1962 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human immunodeficiency virus/acquired immunodeficiency syndrome in the infant;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Machine learning approaches identify immunologic signatures of total and intact HIV DNA during long-term antiretroviral therapy;eLife;2024-09-09

3. Machine learning approaches identify immunologic signatures of total and intact HIV DNA during long-term antiretroviral therapy;eLife;2024-09-09

4. Advancing Toward a Human Immunodeficiency Virus Cure;Infectious Disease Clinics of North America;2024-09

5. Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection;Nature Communications;2024-08-29